Markus M. Valter

1.6k total citations
25 papers, 1.2k citations indexed

About

Markus M. Valter is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Markus M. Valter has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Markus M. Valter's work include Angiogenesis and VEGF in Cancer (4 papers), Glioma Diagnosis and Treatment (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Markus M. Valter is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Glioma Diagnosis and Treatment (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Markus M. Valter collaborates with scholars based in Germany, United States and Australia. Markus M. Valter's co-authors include Jack L. Strominger, Torsten Pietsch, Otmar D. Wiestler, Raif S. Geha, Milena M. Andzelm, Jordan S. Orange, Webster K. Cavenee, Helmut K. Wolf, Huang Huang and Andreas von Deimling and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Acta Neuropathologica and Gynecologic Oncology.

In The Last Decade

Markus M. Valter

25 papers receiving 1.1k citations

Peers

Countries citing papers authored by Markus M. Valter

Since Specialization

Citations

This map shows the geographic impact of Markus M. Valter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus M. Valter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus M. Valter more than expected).

Fields of papers citing papers by Markus M. Valter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus M. Valter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus M. Valter. The network helps show where Markus M. Valter may publish in the future.

Co-authorship network of co-authors of Markus M. Valter

This figure shows the co-authorship network connecting the top 25 collaborators of Markus M. Valter. A scholar is included among the top collaborators of Markus M. Valter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus M. Valter. Markus M. Valter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mask Continuous Positive Airway Pressure Therapy with Simultaneous Extrauterine Placental Transfusion for Resuscitation of Preterm Infants – A Preliminary Study 2018 ·PubMed ·(unknown), (unknown), Ingrid Becker, (unknown), Markus M. Valter, Angela Kribs, André Oberthuer	7
2	Hemolytic Anemia and Methemoglobinemia in a Preterm Baby as a Complication of Antenatal Intraamnial Injection of Toluidine Blue 2013 ·Klinische Pädiatrie ·Katrin Mehler, André Oberthuer, (unknown), Markus M. Valter, Anne Vierzig, Frank Eifinger	3
3	Prevalence and risk factors for oral human papillomavirus infection in 129 women screened for cervical HPV infection 2013 ·Oral Oncology ·Moritz Meyer, Christian U. Huebbers, Oliver Siefer, Julia Vent, (unknown), Guy D. Eslick, Markus M. Valter, Jens Peter Klußmann, Simon F. Preuss	31
4	Experimental studies on the tensile properties of human umbilical cords 2013 ·Forensic Science International ·(unknown), Markus A. Rothschild, Markus M. Valter, (unknown), Sibylle Banaschak	6
5	Optical coherence tomography: A potential tool to predict premature rupture of fetal membranes 2012 ·Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine ·Serap Çilaker Mıçılı, Markus M. Valter, (unknown), Candan Özoğul, Peter Linder, (unknown), G.M. Artmann, Ilya Digel, Ayşegül Temiz Artmann	7
6	Serological and immunohistochemical HER-2/neu statuses do not correlate and lack prognostic value for ovarian cancer patients 2010 ·European Journal of Cancer Care ·Markus Hoopmann, Konrad Sachse, Markus M. Valter, Minerva Becker, R. Neumann, Monika Ortmann, Uwe-Jochen Göhring, A. Thomas, Peter Mallmann, Thomas Schöndorf	12
7	Survey on the use of oxytocin for cesarean section. 2010 ·PubMed ·(unknown), (unknown), H. Lier, Oguzhan Dagtekin, (unknown), Peter Teschendorf, Frank Petzke, Markus M. Valter, (unknown)	19
8	Parametrial and rectovaginal adenocarcinoma arising from endometriosis 2005 ·International Journal of Gynecological Cancer ·U. Ulrich, Kerstin Rhiem, Monique Kaminski, Eva Wardelmann, Daniela Trog, Markus M. Valter, O. Richter	36
9	The V109G Polymorphism of the p27 Gene <i>CDKN1B</i> Indicates a Worse Outcome in Node-Negative Breast Cancer Patients 2004 ·Tumor Biology ·(unknown), Lewin Eisele, (unknown), Markus M. Valter, Mathias Warm, Peter Mallmann, Martina Becker, (unknown), (unknown), Markus Hoopmann	19
10	Differential indication for histological evaluation of endometrial fluid in postmenopause 2004 ·Maturitas ·Torsten C. Schmidt, Frank Nawroth, Martina Breidenbach, Markus Hoopmann, Peter Mallmann, Markus M. Valter	13
11	High Apoptotic Index Correlates to p21 and p27 Expression Indicating a Favorable Outcome of Primary Breast Cancer Patients, but Lacking Prognostic Significance in Multivariate Analysis 2004 ·Pathobiology ·Thomas Schöndorf, Uwe-Jochen Göhring, Martina Becker, Markus Hoopmann, Torsten C. Schmidt, (unknown), Daniel Rein, U. Ulrich, (unknown), (unknown), Peter Mallmann, Markus M. Valter	9
12	Hematological side-effect profiles of individualized chemotherapy regimen for recurrent ovarian cancer 2003 ·Anti-Cancer Drugs ·Martina Breidenbach, Daniel Rein, Thomas Schöndorf, Torsten C. Schmidt, (unknown), Markus M. Valter, Christian M. Kurbacher	18
13	Cisplatin, Doxorubicin and Paclitaxel Induce mdr1 Gene Transcription in Ovarian Cancer Cell Lines 2003 ·Recent results in cancer research ·Thomas Schöndorf, Rainer Neumann, C Benz, Martina Becker, Marion Riffelmann, (unknown), J. Sartorius, Carl-Heinz Wirsing von König, Martina Breidenbach, Markus M. Valter, Markus Hoopmann, Federica Di Nicolantonio, Christian M. Kurbacher	34
14	Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients 2003 ·European Journal of Clinical Investigation ·Thomas Schöndorf, Uwe-Jochen Göhring, Gaël S. Roth, (unknown), Minerva Becker, Natasha Moser, Markus M. Valter, Markus Hoopmann	19
15	Chemopersistent early recurrence in the perineal tear scar of an intrapartally diagnosed cervical cancer 2003 ·Gynecologic Oncology ·Markus Hoopmann, Markus M. Valter, Christian M. Kurbacher, Marc Possover, Peter Mallmann	4
16	Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering 2001 ·Proceedings of the National Academy of Sciences ·Marlys S. Fassett, Daniel M. Davis, Markus M. Valter, George B. Cohen, Jack L. Strominger	94
17	Differential control of VEGF synthesis and secretion in human glioma cells by IL‐1 and EGF 1999 ·International Journal of Developmental Neuroscience ·Markus M. Valter, Otmar D. Wiestler, Torsten Pietsch	44
18	Vascular Endothelial Growth Factor (VEGF) in Astrocytic Gliomas – A Prognostic Factor? 1999 ·Journal of Neuro-Oncology ·(unknown), (unknown), Markus M. Valter, Torsten Pietsch, Jürgen Neumann, Rolf Fimmers, Uwe Schlegel	49
19	Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. 1999 ·PubMed ·Markus M. Valter, (unknown), Hongyi Huang, Webster K. Cavenee, O. D. Wiestler, Torsten Pietsch, Nicolas Wernert	82
20	Expression and distribution of vascular endothelial growth factor protein in human brain tumors 1997 ·Acta Neuropathologica ·Torsten Pietsch, Markus M. Valter, Helmut K. Wolf, Andreas von Deimling, Huang Huang, Webster K. Cavenee, Otmar D. Wiestler	147

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact